Mi-Jung Ahn
Director/Board Member chez GENEXINE, INC.
Fortune : 891 857 $ au 31/03/2024
Profil
Mi-Jung Ahn is currently the Chief Executive Officer at SL Bigen Co. Ltd.
She is also an Independent Director at OCI Holdings Co. Ltd., an Independent Director at Genexine, Inc., and an Outside Director at OCI Co. Ltd.
In the past, she served as an Independent Director at MEDIPOST Co., Ltd.
Dr. Ahn holds graduate degrees from Illinois State University and Chungnam National University, and doctorate degrees from The University of Chicago and Rush University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
GENOMICTREE, INC.
0,23% | 23/01/2024 | 54 206 ( 0,23% ) | 891 857 $ | 31/03/2024 |
Postes actifs de Mi-Jung Ahn
Sociétés | Poste | Début |
---|---|---|
GENEXINE, INC. | Director/Board Member | - |
OCI HOLDINGS COMPANY LTD. | Director/Board Member | 26/03/2019 |
OCI COMPANY LTD. | Director/Board Member | - |
SL Bigen Co. Ltd. | Chief Executive Officer | - |
Anciens postes connus de Mi-Jung Ahn
Sociétés | Poste | Fin |
---|---|---|
MEDIPOST CO., LTD. | Director/Board Member | 29/03/2022 |
Formation de Mi-Jung Ahn
Illinois State University | Graduate Degree |
The University of Chicago | Doctorate Degree |
Rush University | Doctorate Degree |
Chungnam National University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
OCI HOLDINGS COMPANY LTD. | Process Industries |
MEDIPOST CO., LTD. | Transportation |
GENEXINE, INC. | Health Technology |
OCI COMPANY LTD. | Process Industries |
Entreprise privées | 1 |
---|---|
SL Bigen Co. Ltd. |